Insights

Here’s why the Hydrix (ASX: HYD) share price is shooting 70% higher

Detecting potential heart attacks early on can be a lifesaver.
The post Here’s why the Hydrix (ASX: HYD) share price is shooting 70% higher appeared first on The Motley Fool Australia. –

The Hydrix Ltd (ASX: HYD) share price is going gangbusters today, up a huge 70% to 27 cents at the time of writing after rising by as much as 77% in morning trade.

Below we take a look at the medical technologies company’s latest news.

What did Hydrix announce?

The Hydrix share price is soaring after the company reported Angel Medical Systems had advised it that the US Food and Drug Administration has approved its AngelMed Guardian System (AMSG3-E) for commercial release in the United States.

The implantable AngelMed Guardian device constantly monitors patients’ heart signals, alerting them of impending heart attacks. According to the release, it also warns against deadly silent heart attacks. The Guardian is now the world’s first FDA-approved implantable cardiac monitoring device.

Commenting on the approval, Hydrix executive chair Gavin Coote said:

This is a brilliant outcome for AngelMed and Hydrix. The Guardian is a game-changer in cardiac monitoring. It is the world’s only implantable device that can alert a person of an impending heart attack and has the potential to transform patient quality of life.

The FDA approval clears the way for Hydrix to complete regulatory submissions in Asia-Pacific markets commencing with Australia and Singapore.

AngelMed’s CEO, Brad Snow added, “We are excited to commercially launch within weeks in the USA and look forward to supporting Hydrix with its plans to expand our reach into the Asia Pacific market and partner with us to develop next generation device features.”

The company said that with the FDA approval in hand, it will now submit applications for regulatory approvals in Australia and Singapore. It expects the Australian TGA regulatory approval process to take between 6–12 months, while Singapore’s HSA regulatory approval process is forecast to take 9–12 months.

Hydrix share price snapshot

Over the past 12 months the Hydrix share price is up 194%, leaving the 28% gains posted by the All Ordinaries Index (ASX: XAO) well behind.

Year-to-date, however, the Hydrix share price is flat, with much of its 12-month gains having been achieved on a single day last August,

The post Here’s why the Hydrix (ASX: HYD) share price is shooting 70% higher appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

The Incitec Pivot (ASX:IPL) share price has gained 20% in the last 12 months
3 factors for sustainable dividends from small ASX shares

Westpac’s (ASX:WBC) double life insurance divestment looms
Perpetual Ltd (ASX:PPT) share price sets new 52-week high
Amazon could surpass Walmart as America’s largest retailer by next year

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!